Sysmex Corp

Price Chart

Risk-Adjusted Performance

Sysmex Corp (SSMXY) Price Performance

Sysmex Corp (SSMXY) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at $9.11, up 2.13% from the previous close.

Over the past year, SSMXY has traded between a low of $8.23 and a high of $18.59. The stock has lost 51.0% over this period. It is currently 51.0% below its 52-week high.

Sysmex Corp has a market capitalization of $5.31B and a dividend yield of 282.00%.

About Sysmex Corp

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software. It offers non-clinical blood testing and cell analysis for hematology, such as XN-V series, a software for laboratory animal corresponding to XN series fully automated hematology analyzers; XN-Series, a fully automated flagship hematology analyzers; and Automated hematology analyzer ProCyte Dx for Research applications, a housed in a compact body that simultaneously measures five types of leukocytes and reticulocyte counts; coagulation, blood gas/ electrolyte/ urinalysis, cells/ microorganisms, including particle counter/analyzer CDA-1000/1000B, an equipment which is capable of counting cells, yeast, algae, bacteria, and others. The company serves national and other public hospitals, general hospitals, universities, research institutes, other medical institutions, etc. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.